FDA determines available scientific data do not support requiring label warnings on the effectiveness of levonorgestrel emergency contraceptives in women who weigh 165 pounds or more.
In separate documents addressed to health care providers and consumers posted recently to FDA's Postmarket Drug Safety Information website, the...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?